The high circulating level of IL-6 released in COVID-19-infected patients with smoking-related cancers might indicate an host immune inbalance, resulting in an exaggerated immune response and hyperinflammation with a cytokine storm syndrome and severe evolution. Here, IL6 is linked to COVID-19.